Healthcare -
Biotechnology - NASDAQ - US
$ 9.17
-2.96 %
$ 978 M
Market Cap
-3.36
P/E
RCKT - STOCK-BASED COMPENSATION
Stock-based Compensation RCKT - Rocket Pharmaceuticals, Inc.
39.4 M
LAST VALUE
16.10%
2 YEAR CAGR
23.71%
5 YEAR CAGR
74.93%
10 YEAR CAGR